INTERSTITIAL LUNG DISEASE (ILD)

This study is testing the safety of a new inhaled drug, mosliciguat, when added to an existing inhaled medication (treprostinil) for people with pulmonary hypertension caused by scarred lungs (interstitial lung disease). It will enroll about 20 participants who are already using …

This study aims to determine the best way to use a heart-lung machine (called ECMO) during lung transplant surgery. Researchers will compare using the machine for every patient versus only using it when problems arise during surgery. The goal is to see which approach helps patien…

This study is testing whether adding a drug called tetrandrine to standard treatment can better control lung scarring in adults with connective tissue disease-related interstitial lung disease. About 100 participants will take either tetrandrine or a placebo pill for 24 weeks whi…

This study is testing whether a home monitoring program can replace half of the regular hospital visits for people with pulmonary fibrosis. 220 participants will be randomly assigned to either continue standard hospital care or use a home kit with weekly breathing tests, symptom …

This study is testing a new, more efficient way for patients with chronic lung scarring diseases (like pulmonary fibrosis) to attend their regular hospital check-ups. Currently, these visits can be spread over multiple days, requiring separate trips for tests and doctor appointme…

This study is testing whether a more organized and faster diagnostic process can reduce the time it takes for patients to get a clear diagnosis for suspected interstitial lung disease (ILD). It will compare the current standard, often fragmented process to a new, coordinated appr…

This is a first-in-human study to understand how a new inhaled drug, RJ026, moves through the body and how safe it is. It will enroll 84 people, including healthy volunteers and patients with interstitial lung disease (ILD), a condition that causes lung scarring. Researchers will…